Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

2006 ◽  
Vol 274 (2) ◽  
pp. 91-96 ◽  
Author(s):  
A. Papanikolaou ◽  
I. Kalogiannidis ◽  
M. Goutzioulis ◽  
D. Misailidou ◽  
A. Makedos ◽  
...  
2021 ◽  
Vol 162 ◽  
pp. S123-S124
Author(s):  
Olivia Khouri ◽  
Anne Van Arsdale ◽  
Nicole Vilardo ◽  
Divya Gowthaman ◽  
Gregory Gressel ◽  
...  

2019 ◽  
Vol 49 (6) ◽  
pp. 521-524 ◽  
Author(s):  
Shinichi Togami ◽  
Toshihiko Kawamura ◽  
Mika Fukuda ◽  
Shintaro Yanazume ◽  
Masaki Kamio ◽  
...  

2015 ◽  
Vol 11 (4) ◽  
pp. 607-615
Author(s):  
Faina Linkov ◽  
Robert P Edwards ◽  
Andrew Althouse ◽  
Jose A Rauh-Hain ◽  
Marcela G Del Carmen ◽  
...  

2007 ◽  
Vol 17 (5) ◽  
pp. 949-956 ◽  
Author(s):  
S. Tangjitgamol ◽  
S. Manusirivithaya ◽  
C. Lertbutsayanukul

Most patients with endometrial cancer (EMC) present their symptoms early in their course, leading to an overall favorable outcome. However, some patients who are in early-stage diseases may carry some risk features that would hamper their prognoses. For these early-stage diseases with high risk of recurrences, radiation therapy certainly plays a major role as an adjuvant treatment. Despite an excellent local diseases control by radiation, systemic failures are still encountered. To improve the prognoses, other types of adjuvant therapy have been attempted. In this review, various options of adjuvant treatment for this early-stage EMC including radiation therapy, chemotherapy, and hormonal therapy are discussed.


2017 ◽  
Vol 144 (3) ◽  
pp. 515-523 ◽  
Author(s):  
Koji Matsuo ◽  
Hiroko Machida ◽  
Omar M. Ragab ◽  
Tsuyoshi Takiuchi ◽  
Huyen Q. Pham ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document